# A Phase I Study to Evaluate the Oral Absorption of Nepadutant in Infants

> **NCT00655083** · PHASE1 · COMPLETED · sponsor: **Menarini Group** · enrollment: 21 (actual)

## Conditions studied

- Infantile Colic
- Infantile Functional Gastrointestinal Disorders

## Interventions

- **DRUG:** Nepadutant
- **DRUG:** Nepadutant

## Key facts

- **NCT ID:** NCT00655083
- **Lead sponsor:** Menarini Group
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2011-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00655083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00655083, "A Phase I Study to Evaluate the Oral Absorption of Nepadutant in Infants". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00655083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*